Klazidem

Clarithromycin, the active ingredient in Klazidem, is a macrolide antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections, including respiratory, sinus, and skin infections, and is employed in Helicobacter pylori eradication regimens for adult patients.

GNH USA supplies Klazidem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is indicated for several bacterial infection categories, acting primarily on susceptible Gram‑positive and some Gram‑negative organisms.

- Community‑acquired pneumonia: eradicates the causative bacteria and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and infection symptoms. - Acute bacterial exacerbations of chronic bronchitis: helps restore lung function and decrease sputum production. - Skin and soft‑tissue infections: treats cellulitis, erysipelas and other dermal infections. - Helicobacter pylori eradication regimens: used in combination therapy to achieve bacterial clearance.

Clarithromycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be watery. - Abdominal pain: cramping or discomfort in the stomach area. - Altered taste: metallic or bitter sensation. - Headache: mild to moderate intensity. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Hepatotoxicity: elevated liver enzymes or jaundice. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Hepatic failure: rare but life‑threatening liver injury.

Before prescribing Klazidem, clinicians should consider several safety aspects.

- Assess liver function: monitor hepatic enzymes in patients with pre‑existing liver disease. - Monitor cardiac rhythm: avoid in patients with known QT prolongation or arrhythmias. - Avoid use in patients with known macrolide hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in renal impairment: dose adjustment may be required. - Review concomitant medications: consider potential drug‑drug interactions. - Store at below 25°C: keep in the original pack, protect from moisture.

Clarithromycin interacts with several medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Cisapride: may cause serious cardiac arrhythmias. - Pimozide: increased plasma concentrations leading to toxicity. - Ergot alkaloids: risk of ergotism and severe vasospasm.

Moderate Interactions (Monitor Closely): - Statins (simvastatin, lovastatin): heightened risk of myopathy. - Warfarin: enhanced anticoagulant effect, monitor INR. - Theophylline: increased serum levels, watch for toxicity.